Healthcare
Novavax to Participate in September Investor Conferences
Novavax, Inc. (Nasdaq: NVAX) today announced that company management will participate in the following upcoming investor conferences:
About this update from Novavax, Inc.
GAITHERSBURG, Md., Sept. 2, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that company management will participate in the following upcoming investor conferences: A live webcast of the fireside chats will be available on the "Events & Presentations" page of the Company's website at ir.novavax.com . A replay of each webcast will be available for 30 days following the presentation. About Novavax Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including its Matrix-M® adjuvant and protein-based nanoparticles. The Company's corporate growth strategy is designed to deliver value via three key strategic pillars: partnering its technology, capital-efficient research and development (R&D) innovation and a lean and efficient operating model. This includes maximizing impact through partnerships for its marketed products (Nuvaxovid™, R21/Matrix-M™), Matrix technology and R&D assets. Please visit novavax.com and LinkedIn for more information. Contacts: Investors Naina Zaman 844-668-2829 [email protected] Media Yvonne Sprow 844-264-8571 [email protected] View original content to download multimedia: https://www.prnewswire.com/news-releases/novavax-to-participate-in-september-investor-conferences-302867780.html